🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase-I clinical trial to determine the feasibility and safety of...
Status
Terminated
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2011-03
Trial ID
NCT01312376
The purpose of this study is to determine whether a combination of the drug...
Status
Completed
Location
Memorial Sloan-Kettering at Basking Ridge
Start Date
2008-05
Trial ID
NCT00675597
Treatments Being Tested
This study evaluates the interest of regorafenib in combination of metronom...
Status
Recruiting
Location
CHU de Besançon
Start Date
2023-05-09
Trial ID
NCT05462613
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
For patients with recurrent liver cancer after liver transplantation, the m...
Status
Unknown
Location
Department of Liver Transplantation, the Third Affiliated Hospital of Sun Yat-sen University
Start Date
2023-12-03
Trial ID
NCT05833126
Treatments Being Tested
The purpose of this study is to compare the effects (good and bad) of chemo...
Status
Completed
Location
University of Pittsburgh Medical Center
Start Date
2008-10
Trial ID
NCT00703976
Treatments Being Tested
This study is a prospective, randomized phase III, to evaluate if in patien...
Status
Active Not Recruiting
Location
Ospedale San Salvatore
Start Date
2021-04-30
Trial ID
NCT04776655
Treatments Being Tested
This phase II trial studies how well giving bevacizumab, radiation therapy,...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2006-07-25
Trial ID
NCT00321685
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03167177
A randomized, multicenter, Phase III trial evaluating the efficacy and safe...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2025-11-15
Trial ID
NCT07235930
Treatments Being Tested